Zoetis Inc Cl A (ZTS) Stock Price, Quote & News

Company Profile

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermato...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 973 822 7000

Website: www.zoetis.com

Address:

10 Sylvan Way, Parsippany, United States

ParallelCapital Feb. 4 at 11:29 AM

$ZTS is the animal health leader with strong pharmaceutical and vaccine portfolios; pet care spending is resilient.

0 · Reply

ZacksResearch Feb. 3 at 3:10 PM

Is $ZTS set for another earnings surprise? Zoetis boasts an Earnings ESP of +0.84% and a Zacks Rank #3, with Q4 earnings expected at $1.40 per share and revenues pinned at $2.37 billion. Strong demand for Simparica Trio and dermatology brands could drive revenue higher. See the full analysis here 👉 https://www.zacks.com/stock/news/2827958/5-drugbiotech-stocks-likely-to-outperform-q4-earnings-estimates?cid=sm-stocktwits-2-2827958-body-31690&ADID=SYND_STOCKTWITS_TWEET_2_2827958_BODY_31690

0 · Reply

ZacksResearch Feb. 3 at 2:03 PM

Q4 earnings season — these 5 drug & biotech names could surprise to the upside $ZTS, $PCRX, $APLS, $ACAD, and $DNLI are highlighted as poised to beat on fourth-quarter 2025 earnings, setting up a potential outperformance theme investors should have on their radar. See which drug & biotech stocks could deliver earnings upside 👉 https://www.zacks.com/stock/news/2827958/5-drugbiotech-stocks-likely-to-outperform-q4-earnings-estimates?cid=sm-stocktwits-2-2827958-teaser-31624&ADID=SYND_STOCKTWITS_TWEET_2_2827958_TEASER_31624

0 · Reply

Dondurma Feb. 2 at 5:02 PM

$ZTS interested waiting for under 100

0 · Reply

WallStreetBuyDip Feb. 1 at 5:01 AM

$ZTS holding strong at $125 levels while $CHWY struggling around $29. ZTS showing 55% strength compared to CHWY's 20% move. Both stocks trading above average volume but ZTS's volume 45% stronger. Are pets still the investors' best friends in this market?

0 · Reply

JackDarwin Jan. 31 at 11:45 AM

$ZTS Bullish Engulfing Candlestick Pattern

0 · Reply

OnlyFibs Jan. 31 at 1:58 AM

$ZTS quietly putting in work! 9 of the last 12 weeks are green as it bases after that nasty Nov gap down. 🏗️ Institutions seem to be loading up ahead of the Feb 12 earnings. 🐂 Bulls: Need a high-volume close > $130 to confirm the base is solid and target $154+. 🐻 Bears: Looking for a break below $115.25 to invalidate the recovery thesis. Confirming level: $130.00 #ZTS #AnimalHealth #StockMarket #hovdid

0 · Reply

Kevbot29 Jan. 30 at 3:10 PM

$ZTS in with some shares and LEAPS. This is priced for worst case scenario. Risk to reward is good

0 · Reply

AStrokeOfLuck Jan. 22 at 4:13 PM

$ELAN $ZTS

0 · Reply

OfficialStocktwitsUser Jan. 22 at 1:57 PM

$ZTS RSI: 47.66, MACD: 0.1922 Vol: 1.54, MA20: 125.30, MA50: 122.51 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Artisan Global Opportunities Fund Q4 2025 Portfolio Update

ARGX BKR BSX COF COIN INSM LEG

Jan 24, 2026, 8:00 AM EST - 11 days ago

Zoetis: Undervalued And Oversold

Jan 14, 2026, 8:22 AM EST - 21 days ago

Zoetis: Cheap Valuation And Attractive Product Launch Pipeline

Jan 12, 2026, 4:05 PM EST - 22 days ago

Zoetis Inc. (ZTS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 7, 2026, 1:49 PM EST - 27 days ago

Trade Tracker: Stephanie Link sells Eaton and buys more Zoetis, Natera

ETN NTRA

Dec 30, 2025, 8:30 AM EST - 5 weeks ago

Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2025 Financial Results

Dec 29, 2025, 9:59 AM EST - 5 weeks ago

These stocks fell hard in 2025, but analysts see as much as 65% upside for them in 2026

ACN ADBE ALGN CARR CMG CPRT EIX

Dec 23, 2025, 4:04 PM EST - 6 weeks ago

Trade Tracker: Stephanie Link buys mores Zoetis

Dec 18, 2025, 8:30 AM EST - 6 weeks ago

Zoetis to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dec 16, 2025, 1:15 AM EST - 7 weeks ago

Zoetis Announces Pricing of $1.75 Billion Convertible Senior Notes Offering

Dec 15, 2025, 7:09 AM EST - 7 weeks ago

Zoetis Announces Proposed $1.75 Billion Convertible Senior Notes Offering

Dec 15, 2025, 6:47 AM EST - 7 weeks ago

Gabelli Pet Parents' Fund Q3 2025 Contributors And Detractors

CHWY CVS FRPT TRUP WOOF

Dec 11, 2025, 4:15 PM EST - 7 weeks ago

Zoetis Declares First Quarter 2026 Dividend; Board Approves 6% Payment Increase

Dec 8, 2025, 9:03 PM EST - 2 months ago

Top 50 High-Quality Dividend Growth Stocks For December 2025

ACN ALLE APH DHI DPZ FDS GGG

Dec 5, 2025, 8:30 AM EST - 2 months ago

Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats

Dec 4, 2025, 2:08 PM EST - 2 months ago

Zoetis Inc. (ZTS) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Dec 2, 2025, 11:43 AM EST - 2 months ago

Zoetis Inc. (ZTS) Discusses R&D Pipeline Progress and Strategic Vision in Animal Health Innovation Transcript

Dec 2, 2025, 7:30 AM EST - 2 months ago

Zoetis Highlights R&D Leadership and Long-Term Growth Opportunity at Innovation Webcast

Dec 2, 2025, 5:35 AM EST - 2 months ago

Top 15 High-Growth Dividend Stocks For December 2025

ACN ADP BMI DPZ EOG INTU MSCI

Nov 26, 2025, 4:15 PM EST - 2 months ago

Zoetis Receives European Commission Marketing Authorization for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs

Nov 21, 2025, 12:24 PM EST - 2 months ago

Zoetis Osteoarthritis Pain Franchise Needs A Reset: Analyst

Nov 20, 2025, 8:30 AM EST - 2 months ago

Zoetis to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nov 19, 2025, 8:30 AM EST - 2 months ago

Zoetis to Host Innovation Webcast

Nov 17, 2025, 11:24 AM EST - 2 months ago

These stocks have been hit hard in 2025 but could surge by as much as 57% from here

ADBE ALGN BLDR CARR CMG CPRT CRM

Nov 14, 2025, 11:35 AM EST - 2 months ago

Zoetis: A High-Quality Compounder Now On Sale?

Nov 7, 2025, 12:01 PM EST - 3 months ago

Zoetis: Why I'm Still Holding The Stock But Advise Against New Positions

Nov 6, 2025, 9:36 AM EST - 3 months ago

Zoetis Remains A Strong Buy Following Market Overreaction To Q3 Earnings

Nov 4, 2025, 4:16 PM EST - 3 months ago

Zoetis Inc. (ZTS) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 1:15 PM EST - 3 months ago

Zoetis Stock Outlook Clouded By Rising Competitive Pressures

Nov 4, 2025, 12:41 PM EST - 3 months ago

Zoetis: No Longer A Growth Stock

Nov 4, 2025, 8:59 AM EST - 3 months ago

This Animal Health Stock Tanks on Earnings. Pig and Chicken Medication Revenue Slumps.

Nov 4, 2025, 7:44 AM EST - 3 months ago

Zoetis trims annual revenue forecast on muted demand for animal treatments, shares slide

Nov 4, 2025, 7:00 AM EST - 3 months ago

Zoetis Announces Third Quarter 2025 Results

Nov 3, 2025, 4:15 PM EST - 3 months ago

Zoetis Announces Retirement of Rob Polzer at the End of 2025 and the Appointment of Kevin Esch as President of Research & Development for World Leader in Animal Health Beginning in 2026

Nov 3, 2025, 9:30 AM EST - 3 months ago

Zoetis: High-Quality Compounder For Patient Long-Term Dividend Growth Investors

Oct 31, 2025, 10:10 AM EDT - 3 months ago

Buy Zoetis Stock Today?

Oct 29, 2025, 8:30 AM EDT - 3 months ago

Zoetis Receives European Commission Marketing Authorization for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats

Oct 28, 2025, 8:30 AM EDT - 3 months ago

Zoetis Appoints Stephanie Tilenius to its Board of Directors

Oct 21, 2025, 6:48 AM EDT - 3 months ago

Zoetis Stock: Outlook Remains Muted

Oct 15, 2025, 7:00 AM EDT - 4 months ago

Zoetis Announces Health Canada Approval of Lenivia® (izenivetmab injection) for Alleviation of Osteoarthritis (OA) Pain in Dogs

Oct 10, 2025, 4:15 PM EDT - 4 months ago

Zoetis Receives Positive Opinion from CVMP for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs

Oct 9, 2025, 4:15 PM EDT - 4 months ago

Zoetis Declares Fourth Quarter 2025 Dividend

Oct 3, 2025, 10:46 AM EDT - 4 months ago

Top 50 High-Quality Dividend Growth Stocks For October 2025

AAPL ACN ALLE AMAT APH CTAS DHI

Oct 1, 2025, 10:58 PM EDT - 4 months ago

Top 15 High-Growth Dividend Stocks For October 2025

ACN DPZ EOG FDX INTU MSCI NDSN

Sep 30, 2025, 4:15 PM EDT - 4 months ago

Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle

Sep 26, 2025, 10:19 AM EDT - 4 months ago

Pet Pain For Investor Gain

Sep 23, 2025, 8:30 AM EDT - 4 months ago

Zoetis to Host Webcast and Conference Call on Third Quarter 2025 Financial Results

Sep 12, 2025, 12:09 PM EDT - 5 months ago

Zoetis Receives Positive Opinion from CVMP for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats

Sep 8, 2025, 4:16 PM EDT - 5 months ago

Zoetis Inc. (ZTS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 6, 2025, 12:18 PM EDT - 5 months ago

Top 50 High-Quality Dividend Stocks For September 2025

AAPL ACN ALLE AMAT APH CTAS DHI

ParallelCapital Feb. 4 at 11:29 AM

$ZTS is the animal health leader with strong pharmaceutical and vaccine portfolios; pet care spending is resilient.

0 · Reply

ZacksResearch Feb. 3 at 3:10 PM

0 · Reply

ZacksResearch Feb. 3 at 2:03 PM

0 · Reply

Dondurma Feb. 2 at 5:02 PM

$ZTS interested waiting for under 100

0 · Reply

WallStreetBuyDip Feb. 1 at 5:01 AM

0 · Reply

JackDarwin Jan. 31 at 11:45 AM

$ZTS Bullish Engulfing Candlestick Pattern

0 · Reply

OnlyFibs Jan. 31 at 1:58 AM

0 · Reply

Kevbot29 Jan. 30 at 3:10 PM

$ZTS in with some shares and LEAPS. This is priced for worst case scenario. Risk to reward is good

0 · Reply

AStrokeOfLuck Jan. 22 at 4:13 PM

$ELAN $ZTS

0 · Reply

OfficialStocktwitsUser Jan. 22 at 1:57 PM

0 · Reply

briefingcom Jan. 22 at 1:49 PM

$ZTS: Zoetis downgraded to Neutral from Overweight at Piper Sandler; tgt $135 https://www.briefing.com/calendars/updown?Filter=downgrades&utm_campaign=updown&utm_medium=social&utm_source=x&utm_content=link

0 · Reply

anachartanalyst Jan. 22 at 12:01 PM

$ZTS https://anachart.com/wp-content/uploads/ana_temp/1769083278_soc-img.jpg

0 · Reply

theflynews Jan. 22 at 10:42 AM

Piper downgrades Zoetis to Neutral on innovation 'air pocket' - $ZTS - https://legacy.thefly.com/permalinks/entry.php/ZTSid4275438?17690785

0 · Reply

BullishPullBacks Jan. 21 at 5:51 PM

$ZTS pretty strong, I'm in.

0 · Reply

JillMoneyLopez Jan. 19 at 8:52 PM

$ZTS is one of those businesses where the debate isn’t quality, it’s really about expectations. When you back into the current price with a reverse DCF, the growth assumptions are reasonable but not trivial for a mature animal health leader. Interesting setup for disciplined investors in my opinion, but not a screaming buy.

1 · Reply

Godwins26 Jan. 15 at 2:06 PM

Watchlist today 😊 $IVP $CHWY $WOOF $ZTS $FRPT

0 · Reply

Godwins26 Jan. 15 at 4:29 AM

Watchlist 🐕 $IVP up 256% $CHWY $WOOF $ZTS $FRPT

0 · Reply

Godwins26 Jan. 15 at 4:08 AM

Animal Watchlist 🐕 $IVP up 260% $CHWY $WOOF $ZTS $FRPT

0 · Reply

TheRealShortSqueezy Jan. 14 at 2:30 PM

$PETV Just Dropped News 📰 Digital Landia’s AgenticPet surpassed 1,000+ active beta users in under 72 hours, signaling strong demand for AI-powered preventive pet healthcare. Key highlights: 🔸1,000+ beta users onboarded under 72 hours 🔸 Confirms demand for proactive, AI-driven pet health monitoring 🔸 Powered by 10 specialized AI agents (Veterinarian, Behaviorist, Geneticist, Radiologist, etc.) 🔸 Early users report detection of health, stress, and behavioral issues previously unnoticed 🔸 Backed by an exclusive 10-year partnership with PetVivo Holdings 🔸 Partnership provides access to ~8,500 veterinary clinics nationwide Momentum is building and PETV sits at the center of AI-driven preventive pet care. Communicated Disclaimer: https://stockresearchtoday.com/better-pet-care-through-joint-therapy-solutions/ Sector Peers: $ZTS $IDXX $ELAN $PAHC

0 · Reply

OnlyFibs Jan. 14 at 1:10 AM

$ZTS is currently navigating a tight consolidation range after a period of volatility. While the long-term trend has been challenged, the stock is showing signs of stabilizing as it holds near its recently raised dividend level and approaches its Q4 earnings report on February 12th. Institutional interest remains a tailwind, with recent stake increases providing a floor for the price action. Key Levels to Confirm: 🐂 Bulls: Need a clean daily close above $127.23 to confirm a short-term reversal and target the next major resistance at $130.00. 🐻 Bears: A break below the $123.31 intraday low risks a retest of the critical 52-week support at $115.25. #hovdid

0 · Reply

BillionerOfKing Jan. 13 at 4:53 PM

$ZTS Current Stock Price: $124.19 Contracts to trade: $125 ZTS Jan 16 2026 Call Entry: $1.00 Exit: $1.87 ROI: 87% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

scalpemfast Jan. 10 at 4:16 AM

$ZTS ,$AMGN ,$AMZN, put this on your screen!!! It will happen. My opinion

1 · Reply

Market Cap	55.01B
Revenue (ttm)	9.26B
Net Income (ttm)	2.49B
EPS (ttm)	N/A
PE Ratio	19.20
Forward PE	17.89
Profit Margin	26.86%
Debt to Equity Ratio	1.31

Volume	3,816,100
Avg Vol	5,244,114
Day's Range	N/A - N/A
Shares Out	440.69M
Stochastic %K	37%
Beta	0.97
Analysts	Sell
Price Target	$152.27